Wednesday, December 07, 2022

US diverts COVID-19 funds to secure vaccines amid standoff

Virus Outbreak Biden 22159470693660

FILE – Pre-loaded syringes with the COVID-19 vaccine are ready, as medical staff vaccinate students at the KIPP Believe Charter School in New Orleans, January 25, 2022. More than $10 billion in coronavirus relief funds are being diverted from stay-at-home orders. Rapid tests and other epidemiological efforts. The White House on Wednesday blamed a lack of funding for the move and said it was trying to come up with money to secure the next generation of vaccines and treatments for some high-risk Americans. ( Associated Press Photo/Ted Jackson, FILE)

WASHINGTON ( Associated Press) – The Biden administration said Wednesday that a funding crunch is forcing it to divert more than $10 billion in coronavirus relief from test purchases and other efforts as it seeks to secure the next generation of vaccines and treatments. Tries to come up with money. Some high-risk Americans.

The White House Said It Has Been Abandoned “no option” But to cut down on orders for rapid tests at home, which has favored a domestic manufacturing base for easier diagnostic tests. It is withdrawing funding for research and development of new COVID-19 vaccines and limiting orders for personal protective equipment in an effort to maintain some stockpile of vaccines and treatments for Americans heading into the winter.

Still, the Democratic administration says, there will be enough money available to provide treatments and vaccines to some people. It urged Congress to act to provide enough money to secure supplements for all who want or may need them.

“The administration will have to act because Congress will not,” The White House said in a statement. “These trade-offs we are being forced to make due to Congress will have dire consequences on next generation vaccines, therapeutics and diagnostics, domestic vaccine production capacity, stockpiles of PPE and procurement of testing and testing supplies. and community health centers. ,

the White House said “not acceptable” The trade-offs were due to the inaction of Congress.

It wasn’t immediately clear which vaccines and treatments the administration was seeking to secure with limited funding — including that the administration was ordering a potential majority of vaccines that would both protect against the original COVID-19 strain and against certain variants. will provide targeted protection. The White House also did not specify how many doses of the vaccines would be achieved, citing contract requirements for lack of clarity.

The administration said Wednesday’s move would divert $5 billion to purchase COVID-19 vaccine doses for the fall, $4.9 billion for 10 million Paxlovid oral antiviral treatment courses, and $300 million to purchase additional monoclonal antibody treatments.

The Biden administration is warning for months of potential for rationing and other difficult trade-offs if Congress doesn’t act to provide additional funding, saying it will boost people’s immunity from booster doses or from prior infections. I will spend my life.

Lawmakers in March appeared to be nearing a $22.5 billion $10 billion deal requested by President Joe Biden, but talks broke down over Biden’s plans to end pandemic-related public health restrictions at US borders, which have severely affected migration. substantially reduced. Although that move has been blocked by a federal judge, lawmakers have appeared no closer to reaching a deal.

The White House has said that if it does not act swiftly to secure vaccines, other nations will lock their places ahead of the US, which tends to be America’s first nation if not first nation. will reverse. , to market vaccines and life-saving COVID-19 treatments such as Paxlovid.

News bulletin

Join the thousands who have already received our daily newsletter.

Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.

Latest News

Related Stories